Top Video Laryngoscope Companies

Video Laryngoscope Market size was valued at USD 136.86 Million in 2024 and is poised to grow from USD 143.84 Million in 2025 to USD 214.14 Million by 2033, growing at a CAGR of 5.1% during the forecast period (2026–2033).

The global video laryngoscope market is relatively fragmented, with a high level of competition. Few large players, like Prodol Meditec, Ambu A/S, Medtronic, KARL STORZ SE & Co. KG, Nihon Kohden Corporation, Verathon Inc., Salter Labs, VDO Medical Inc., AAM Healthcare, Hebei Vimed Medical Device Company, Ltd., Olympus Corporation., now control the market in terms of market share. These industry leaders are extending their customer base across several areas, and many corporations are creating strategic and collaborative initiatives with other start-up enterprises to enhance their market share and profitability. 'Medtronic ', 'KARL STORZ SE & Co. KG ', 'Nihon Kohden Corporation ', 'Verathon Inc. ', 'Ambu A/S ', 'AAM Healthcare ', 'Hebei Vimed Medical Device Company, Ltd. ', 'VDO Medical Inc. ', 'Marshall Products ', 'Olympus Corporation ', 'Clarus Medical LLC ', 'B. Braun Melsungen AG ', 'VYAIRE MEDICAL, INC. ', 'Intersurgical Ltd. ', 'King SystemsSunMed LLC ', 'Truphatek International Ltd. ', 'UE Medical Devices Inc. ', 'XION GmbH ', 'Propper Manufacturing Co. Inc. ', 'Timesco Healthcare Ltd. '

Increased demand for healthcare facilities and the significance of communicating results with patients are factors driving the growth of the global market for video laryngoscopes. In order to detect and cure the disease, video laryngoscopy is also in demand due to the cutting-edge technology and enhanced resolution.

One of the major developments influencing the laryngoscope industry is robotic assistance in laryngoscopy. Robot-assisted laryngoscopy is becoming more and more popular due to the growing hazards and difficulties that come with cutting-edge and experimental techniques.

The video laryngoscopes market was dominated by North America in 2021, which also had the highest revenue share at approximately 41.1%. The high prevalence of respiratory problems in both the adult and pediatric populations can be blamed for the rise. Additionally, it is projected that the market will be driven by rising air pollution and exposure to cigarette smoke, which causes respiratory illnesses. Strict practice standards established by the American Society of Anaesthesiologists (ASA) and other healthcare organizations, along with expanding regional government efforts, are anticipated to spur market expansion.